Jiuzhitang Yonghe Qihang Fund plans to invest in the establishment of Jiuzhitang Maker.


2018-02-02

On February 2, 2018, Jiuzhitang Co., Ltd. announced that the Jiuzhitang Yonghe Qihang Fund plans to invest 200 million yuan to establish Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd. On March 13, Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd. was officially founded as the sole entity inheriting Stemedica Corporation's stem cell technology from the U.S. On March 27, the company acquired a 4,500-square-meter factory building in the Beijing Daxing District Biomedical Base of Zhongguancun Science Park, marking the start of its ambitious plan to build a state-of-the-art stem cell R&D and manufacturing center compliant with Chinese, U.S., and EU regulatory standards.

Next: